Mita Kuchimanchi

3PUBLICATIONS
3CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 09, 2024
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.

Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze

|Feb 24, 2023
Dostarlimab, an anti-programmed death-1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration-QT analysis.

Mita Kuchimanchi, Christine Dabrowski, Sharon Lu

|Jan 16, 2019
Exposure-response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy.

Mita Kuchimanchi, Min Zhu, John D Clements

Pageof 1

Frequent Collaborators

1 joint publications

Min Zhu

1 joint publications

John D Clements

1 joint publications

Sameer Doshi